Aligos Therapeutics Correlations

Aligos Therapeutics Correlation to Market

Aligos Therapeutics has a market cap of 39.85 million, an operating margin of -9.52% on a trailing twelve-month basis, compared to -42.26% in the last reported annual period, current ratio of 5.3. Portfolio construction methods define how positions are sized relative to each other. Broader economic conditions can influence Aligos Therapeutics's company valuation - related indicators include signals in price.For more detail on Aligos Stock please use our How to Invest in Aligos Stock guide.

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations OKUR + 0.79 XFOR INMB + 0.69 BRNS OKUR + 0.68 KZR SKYE + 0.63 INMB XFOR + 0.52 KZR SKYE + 0.42 BRNS

High negative correlations OKUR - 0.69 TPST CVM - 0.59 XFOR CVM - 0.56 OKUR TPST - 0.52 XFOR CVM - 0.5 KZR TPST - 0.46 KZR

Risk-Adjusted Indicators

Headline performance for Aligos Stock may not fully reflect how the business compares across its competitive set. Peer-relative risk metrics add context on drawdown behavior, consistency, and return quality. These indicators are quantitative in nature and measure volatility and risk-adjusted expected returns across different positions.